A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC) (Q67509725)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 December 1992
edit
Language Label Description Also known as
English
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)
scientific article published on 01 December 1992

    Statements

    A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC) (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit